article thumbnail

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

STAT

for 2018 and 2020. In what one U.S. lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceutical company in history, Pfizer sold $20 billion in medicines to U.S. customers, but treating the profits as foreign income for tax purposes.

article thumbnail

What will it take to end health care worker burnout?

STAT

Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…

Hospitals 358
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: HIV self-testing is easy, effective — and underutilized

STAT

In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region.

241
241
article thumbnail

STAT+: The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat

STAT

Then, in 2018, she finally found a drug that kept her ADHD in check.  STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years.   Continue to STAT+ to read the full story…

article thumbnail

USDA, FDA turf battles hamper responses to outbreaks like H5N1 bird flu

STAT

WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food.

363
363
article thumbnail

Merck Ebola vaccine Ervebo shown to offer substantial protection

STAT

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had been vaccinated at least 10 days before being exposed to the virus, a new study reports.

Vaccines 363
article thumbnail

The XBI biotech index hit its lowest point since 2018. No one knows what comes next.

STAT

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology. Read the rest…